Tandem Diabetes Care Expands EU Approval for Insulin Pumps
Tandem Diabetes Care (NASDAQ:TNDM) has received CE mark approval in the European Union, expanding the use of its insulin delivery systems t:slim X2 and Tandem Mobi. This regulatory clearance broadens their application within diabetes management.
Tickers: $TNDM
Topics: diabetes_care medical_devices